and all demonstrated improvements in the use of VTE prophylaxis. Most studies evaluated change in provider behaviour, not patient outcome, and no study that evaluated outcomes demonstrated a reduction ...

Adjust dosage ... prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction or when administered (in conjunction with warfarin) as inpatient treatment of acute ...

The incidence of symptomatic acute deep-vein thrombosis (DVT) in the general population is very low in those under the age of 50. It increases to 5.11 episodes per year per 1000 city-dwelling ...

Primary thrombosis prevention in persistently ... of choice in these patients The current recommendation is low-dose aspirin and heparin for the prevention of fetal loss in persistently aPL ...

and discuss its potential use for disease prophylaxis versus disease therapy. We also highlight the concerns of using this anticoagulant in COVID-19. Enoxaparin, being a low molecular weight heparin ...

Objective: The aim of this study was to compare the efficacy and safety for particular regimen and dosage in venous thromboembolism ... diagnosed with DVT and/or PE or required VTE prophylaxis; (3) ...